Coming soon:

neonavia A new system for breast biopsy with micro-pulse control

NeoNavia® - A new biopsy system

The advances in breast cancer screening, imaging and breast cancer care have created new conditions also for development of new technologies and techniques for tissue sampling in breasts and axillary lymph nodes.

Read more about NeoNavia here

One of the innovations of our biopsy system is the technology for needle insertion through healthy tissue and exact placement in a suspicious lesion. The technology is patented and called micro-pulse technology.

Read more about the technology here

NeoDynamics AB (publ) is a Swedish Medical Technology Company dedicated to advancing diagnosis and care of breast cancer.

Read more about us

The biopsy system NeoNavia can safely increase the precision of ultrasound-led, technically difficult biopsies such as in the armpit lymph nodes1

Dr Steven Allen, Consultant Radiologist, Royal Marsden NHS Foundation Trust, UK
Do you want to participate and evaluate NeoNavia today?
Try NeoNavia
1) J. Lee, B. Bishop, S. Allen; The Royal Marsden NHS Foundation Trust, London; Oxford University Hospitals NHS Foundation Trust, Oxford, UK; Published in Breast Cancer Research 2017, 19(Suppl 1):PB.39